Precision Biosciences (DTIL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $5.77, -6.48% vs the prior close of $6.17.
- Volume 300.25K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DTIL slides 6.5% to $5.77, a 6-month low. Closed at $5.77, -6.48% vs the prior close of $6.17. Day range $5.73–$6.18, opened at $6.18.
DTIL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — DTIL slides 6.5% to $5.77, a 6-month low
- Closed at $5.77, -6.48% vs the prior close of $6.17. Day range $5.73–$6.18, opened at $6.18.
- Volume was 300.25K shares, 1.1x its 50-day average of 264.81K.
- Price is -18.6% vs its 50-day average ($7.09) and -9.9% vs its 200-day average ($6.40).
- 52-week range $3.53–$9.62; today's close sits at 37% of that range, 40.0% below the 52-week high.
Oct 15, 2026 — DTIL rises 2.3% to $6.17
- Closed at $6.17, +2.32% vs the prior close of $6.03. Day range $5.98–$6.20, opened at $6.04.
- Volume was 246.10K shares, 0.9x its 50-day average of 265.22K.
- Price is -13.4% vs its 50-day average ($7.12) and -3.5% vs its 200-day average ($6.40).
- 52-week range $3.53–$9.62; today's close sits at 43% of that range, 35.9% below the 52-week high.
Oct 14, 2026 — DTIL dips 1.1% to $6.03, a 6-month low, 3 down days in a row
- Closed at $6.03, -1.15% vs the prior close of $6.10. Day range $5.92–$6.25, opened at $6.05.
- Volume was 294.20K shares, 1.1x its 50-day average of 267.00K.
- Price is -15.6% vs its 50-day average ($7.15) and -5.6% vs its 200-day average ($6.39).
- 52-week range $3.53–$9.62; today's close sits at 41% of that range, 37.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — DTIL slides 6.6% to $6.10, a 3-month low
- Closed at $6.10, -6.58% vs the prior close of $6.53. Day range $6.05–$6.55, opened at $6.51.
- Volume was 326.70K shares, 1.2x its 50-day average of 266.20K.
- Price is -15.0% vs its 50-day average ($7.17) and -4.4% vs its 200-day average ($6.38).
- 52-week range $3.53–$9.62; today's close sits at 42% of that range, 36.6% below the 52-week high.
Oct 12, 2026 — DTIL dips 2.8% to $6.53
- Closed at $6.53, -2.83% vs the prior close of $6.72. Day range $6.45–$6.73, opened at $6.71.
- Volume was 228.80K shares, 0.9x its 50-day average of 265.85K.
- Price is -9.2% vs its 50-day average ($7.19) and +2.5% vs its 200-day average ($6.37).
- 52-week range $3.53–$9.62; today's close sits at 49% of that range, 32.1% below the 52-week high.
Oct 9, 2026 — DTIL jumps 4.5% to $6.72, 3 up days in a row
- Closed at $6.72, +4.51% vs the prior close of $6.43. Day range $6.35–$6.92, opened at $6.43.
- Volume was 263.70K shares, 1.0x its 50-day average of 265.29K.
- Price is -6.7% vs its 50-day average ($7.20) and +5.7% vs its 200-day average ($6.36).
- 52-week range $3.53–$9.62; today's close sits at 52% of that range, 30.1% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — DTIL rises 2.9% to $6.43
- Closed at $6.43, +2.88% vs the prior close of $6.25. Day range $6.19–$6.53, opened at $6.25.
- Volume was 332.50K shares, 1.3x its 50-day average of 264.67K.
- Price is -10.8% vs its 50-day average ($7.21) and +1.3% vs its 200-day average ($6.35).
- 52-week range $3.53–$9.62; today's close sits at 48% of that range, 33.2% below the 52-week high.
Oct 7, 2026 — DTIL rises 0.8% to $6.25
- Closed at $6.25, +0.81% vs the prior close of $6.20. Day range $6.11–$6.38, opened at $6.20.
- Volume was 162.50K shares, 0.6x its 50-day average of 265.01K.
- Price is -13.4% vs its 50-day average ($7.22) and -1.4% vs its 200-day average ($6.34).
- 52-week range $3.53–$9.62; today's close sits at 45% of that range, 35.0% below the 52-week high.
Oct 6, 2026 — DTIL dips 1.7% to $6.20, 3 down days in a row
- Closed at $6.20, -1.74% vs the prior close of $6.31. Day range $6.11–$6.40, opened at $6.36.
- Volume was 191.00K shares, 0.7x its 50-day average of 266.20K.
- Price is -14.3% vs its 50-day average ($7.24) and -2.0% vs its 200-day average ($6.33).
- 52-week range $3.53–$9.62; today's close sits at 44% of that range, 35.6% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — DTIL ends flat (+0.0%) to $6.31
- Closed at $6.31, +0.00% vs the prior close of $6.31. Day range $5.97–$6.38, opened at $6.36.
- Volume was 218.80K shares, 0.8x its 50-day average of 265.67K.
- Price is -13.0% vs its 50-day average ($7.26) and -0.2% vs its 200-day average ($6.32).
- 52-week range $3.53–$9.62; today's close sits at 46% of that range, 34.4% below the 52-week high.
Oct 2, 2026 — DTIL dips 0.3% to $6.31
- Closed at $6.31, -0.32% vs the prior close of $6.33. Day range $6.20–$6.44, opened at $6.42.
- Volume was 293.00K shares, 1.1x its 50-day average of 264.68K.
- Price is -13.3% vs its 50-day average ($7.28) and -0.1% vs its 200-day average ($6.31).
- 52-week range $3.53–$9.62; today's close sits at 46% of that range, 34.4% below the 52-week high.
DTIL latest news & SEC filings
Every SEC filing by or about DTIL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Frankel Stanley bought 1,000 shares at $6.00 (≈$6.00K) on Sep 28, 2026; now holds 41,478
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brown Melinda bought 1,135 shares at $6.27 (≈$7.12K) on Sep 25, 2026; now holds 45,481
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Germano Geno J bought 2,609 shares at $6.28 (≈$16.38K) on Sep 25, 2026; now holds 47,492
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 7, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $18.00K) (-100.0% vs Jun 30, 2025)
- Net income: -$32.65M (prior year -$23.52M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.26 (prior year -$2.13) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 3, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 3, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 20, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade DTIL
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 12, 2026, Jan 13, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.01% (largest 11.5%). That is a volatile stock.
- Liquidity: about 269.57K shares (≈$1.56M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $5.77 vs a range of $3.53–$9.62 (37% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 13 sales; latest: Stanley Frankel bought 1,000 shares on Sep 28, 2026.
- Latest filings: 8-K Aug 24, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 27.60M shares outstanding (Aug 3, 2026), +134.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
DTIL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.18 | 6.18 | 5.73 | 5.77 | 300.25K |
| Oct 15, 2026 | 6.04 | 6.20 | 5.98 | 6.17 | 246.10K |
| Oct 14, 2026 | 6.05 | 6.25 | 5.92 | 6.03 | 294.20K |
| Oct 13, 2026 | 6.51 | 6.55 | 6.05 | 6.10 | 326.70K |
| Oct 12, 2026 | 6.71 | 6.73 | 6.45 | 6.53 | 228.80K |
| Oct 9, 2026 | 6.43 | 6.92 | 6.35 | 6.72 | 263.70K |
| Oct 8, 2026 | 6.25 | 6.53 | 6.19 | 6.43 | 332.50K |
| Oct 7, 2026 | 6.20 | 6.38 | 6.11 | 6.25 | 162.50K |
| Oct 6, 2026 | 6.36 | 6.40 | 6.11 | 6.20 | 191.00K |
| Oct 5, 2026 | 6.36 | 6.38 | 5.97 | 6.31 | 218.80K |
| Oct 2, 2026 | 6.42 | 6.44 | 6.20 | 6.31 | 293.00K |
| Oct 1, 2026 | 6.33 | 6.47 | 6.24 | 6.33 | 242.20K |
| Sep 30, 2026 | 6.24 | 6.40 | 6.14 | 6.26 | 249.20K |
| Sep 29, 2026 | 6.37 | 6.45 | 6.08 | 6.18 | 154.10K |
| Sep 28, 2026 | 6.21 | 6.26 | 6.00 | 6.24 | 222.80K |
| Sep 25, 2026 | 6.35 | 6.55 | 6.18 | 6.22 | 204.00K |
| Sep 24, 2026 | 6.31 | 6.47 | 6.18 | 6.33 | 401.80K |
| Sep 23, 2026 | 7.16 | 7.17 | 6.34 | 6.36 | 355.90K |
| Sep 22, 2026 | 6.57 | 7.31 | 6.55 | 7.19 | 431.60K |
| Sep 21, 2026 | 6.73 | 6.75 | 6.44 | 6.50 | 272.30K |
About Precision Biosciences
Precision Biosciences (DTIL) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in DURHAM, NC. State of incorporation: DE. Fiscal year ends May 21. SEC CIK 1357874.
DTIL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Michael Amoroso | President and CEO | Jun 3, 2026 |
| Melinda Brown | Director | Sep 29, 2026 |
| Kevin Buehler | Director | Jun 5, 2026 |
| Stanley Frankel | Director | Sep 30, 2026 |
| Geno J Germano | Director | Sep 29, 2026 |
| Shari Lisa Pire | Director | Jun 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Amoroso | President and CEO | Jun 3, 2026 |
| Mei Zhang Lu Burris | Chielf Accounting Officer | Aug 3, 2026 |
| Cassandra Louise Gorsuch | Chief Scientific Officer | Aug 3, 2026 |
| John Alexander Kelly | Chief Financial Officer | Jun 3, 2026 |
| J. Jefferson Smith | Chief Research Officer | Jun 3, 2026 |
| Dario Scimeca | General Counsel and Secretary | Jun 3, 2026 |
| Naresh Haresh Tanna | Chief Financial Officer | Aug 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | Stanley Frankel | Buy | 1,000 | $6.00 |
| Sep 28, 2026 | Stanley Frankel | Buy | 1,000 | $6.00 |
| Sep 28, 2026 | Stanley Frankel | Buy | 1,000 | $6.00 |
| Sep 28, 2026 | Stanley Frankel | Buy | 1,000 | $6.00 |
| Sep 25, 2026 | Melinda Brown | Buy | 1,135 | $6.27 |
| Sep 25, 2026 | Melinda Brown | Buy | 1,135 | $6.27 |
| Sep 25, 2026 | Melinda Brown | Buy | 1,135 | $6.27 |
| Sep 25, 2026 | Melinda Brown | Buy | 1,135 | $6.27 |
| Sep 25, 2026 | Geno J Germano | Buy | 2,609 | $6.28 |
| Sep 25, 2026 | Geno J Germano | Buy | 2,609 | $6.28 |
| Sep 25, 2026 | Geno J Germano | Buy | 2,609 | $6.28 |
| Sep 25, 2026 | Geno J Germano | Buy | 2,609 | $6.28 |
| Feb 18, 2026 | Michael Amoroso | Sale | 20,559 | $3.84 |
| Feb 18, 2026 | Michael Amoroso | Sale | 20,559 | $3.84 |
| Feb 18, 2026 | Michael Amoroso | Sale | 20,559 | $3.84 |
DTIL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $34.26M | $-45.72M | -3.56 | $-65.84M |
| Dec 31, 2024 | $68.70M | $7.17M | 1.04 | $-58.45M |
| Dec 31, 2023 | $48.73M | $-61.32M | -15.96 | $-84.11M |
| Dec 31, 2022 | $25.10M | $-111.64M | -38.10 | $-45.75M |
| Dec 31, 2021 | $115.53M | $-30.60M | -0.52 | $-10.85M |
Latest balance sheet: total assets $125.92M, total liabilities $80.63M, cash $86.08M (as of Jun 30, 2026).
DTIL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $7.42 |
| May 5, 2026 | 8-K Item 2.02 (results) | $7.45 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $5.67 |
| Jan 13, 2026 | 8-K Item 2.02 (results) | $4.11 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $7.36 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $4.57 |
| May 15, 2025 | 8-K Item 2.02 (results) | $4.55 |
| Mar 26, 2025 | 8-K Item 2.02 (results) | $4.53 |
| Jan 8, 2025 | 8-K Item 2.02 (results) | $4.50 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $8.29 |
| Oct 24, 2024 | 8-K Item 2.02 (results) | $8.48 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DTIL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.